10/12/2003
ReGen Therapeutics Plc (‘ReGen’ or ‘the Company’) announces that it has today placed with new and existing shareholders 32.6 million new ordinary shares (‘New Shares’) at 2p per share to raise £652,000 before expenses (‘Placing’).
Application has been made for the New Shares to be admitted to the Alternative Investment Market of the London Stock Exchange Plc and dealings are expected to commence at 8am on 16th December 2003.
Executive Chairman Percy Lomax commented ‘The Placing price of 2p is one third higher than the last placing in July and compares very favourably with the 0.75p placing price in April. During the current year the Company has raised £2.6m. I am very pleased to see the company in a financial position to continue the current Research and Development programme.’
For further information please contact:
Andrew Marshall
Marshall Robinson Roe
Tel No 020 7960 6007